To which one of the following cancer drugs did India grant its first compulsory licence?
Question and options
To which one of the following cancer drugs did India grant its first compulsory licence?
- Nexavar
- Nelofer
- Abraxane
- Nicolette
Answer and explanation
Correct answer: A - Nexavar
In March 2012 India granted its first compulsory licence under section 84 of the Patents Act, 1970 to Natco Pharma for Bayer's Nexavar (sorafenib tosylate), a kidney and liver cancer drug. Abraxane is a real cancer drug, but it was not the subject of that licence.
Practice for these exams
-
All India Bar Examination (AIBE)
Subject revision
See pack details on LawMint.net -
UGC NET Law
Subject revision
See pack details on LawMint.net -
IIT Kharagpur LL.M. Entrance
Subject revision
See pack details on LawMint.net -
CUSAT CAT Integrated IPR Ph.D.
-
CUET PG Law (LL.M.)
Subject revision
-
Patent Agent
Subject revision
Related question papers
Related exam syllabi
More solved explanations in Patents Act, 1970
- Mr. Allu's name was removed from register of Patent Agent on 25/03/2023. Now, Mr. Allu wants to file an application for restoration of his name in the register of…
- Which of the following constitutes patentable subject matter? I. A toxin- where such toxin is found on the skin of a previously unknown tree frog of the Amazon…
- Which of the following statements is correct under Section 91 of the Patents Act, 1970?
- Section 57 of the Patents Act, 1970 deals with:
- According to Section 83(f) of the Patents Act, 1970, the patent right: